Leiyunshang Pharmaceutical Group

Leiyunshang Group was founded in 1734. The founder, Lei Dasheng (1696–1779), courtesy name Yunshang and art name Nanshan, was a renowned physician of the Wu School of Medicine during the Qing Dynasty and a leading representative who brought the school of medicine’s academic tradition to its fullest development. For over 300 years, adhering to the mission of “Gathering a Hundred Herbs to Benefit All People” and the ancestral precept of “Selecting authentic medicinal materials with integrity, and dedicating ourselves to crafting superior pills, powders, ointments, and elixirs,” Leiyunshang has upheld integrity and pursued innovation. Positioned as “a leader in intelligent and evidence-based traditional Chinese medicine,” it has developed into a science-driven, innovation-oriented modern TCM enterprise.

Leiyunshang Pharmaceutical Group Co., Ltd. (hereinafter referred to as “Leiyunshang Group”) is headquartered in Suzhou. As one of China’s four major traditional pharmaceutical houses, it is a nationally recognized time-honored brand, and the holder of nationally classified confidential projects and national intangible cultural heritage. Rooted in traditional Chinese medicine (TCM), the Group inherits and carries forward the essence of the Warm Disease Theory, fully leverages modern scientific and technological achievements, and vigorously promotes the modernization of the TCM industry. Today, Leiyunshang Group has grown into an industrial cluster integrating the R&D, production and sales of Chinese patent medicines, pharmaceutical retail, technological healthcare and TCM clinics. Through organic growth and strategic expansion, the Group has steadily enhanced its industrial competitiveness. It now owns 13 subsidiaries and affiliated enterprises located in Suzhou, Anhui, Beijing, Guangdong, Changchun, Shenyang, Yunnan, Shaanxi and other regions.

Focusing on its strengths in Chinese patent drugs, Leiyunshang Group concentrates on major diseases, cultivates flagship products, and has established a diversified and comprehensive product pipeline. Its product portfolio covers cardiovascular and cerebrovascular diseases as well as respiratory diseases, with further expansion into urology, oncology, orthopedics, gastroenterology and metabolic disorders. The Group boasts a series of distinctive traditional Chinese medicine products, including the celebrated throat remedy Liushen Pills, the time-honored classical prescription Suhexiang Pills, the nationally recognized top-grade Jianyanling Capsules, Compound Congrong Yizhi Capsules developed based on the clinical experience of Academician Wang Yongyan, natural botanical Qianggu Capsules, and Lingbao Heart-Protecting Pills known as the “pharmaceutical pacemaker.” Other key products include Angong Niuhuang Pills, Kuhuang Injection/Granules, Bufei Huoxue Capsules, Qingke Pingchuan Granules, Shuangdan Mingmu Capsules, the Nao’an series, Xiaozheng Pills, Pediatric Guangpu Antidiarrheal Oral Liquid, Shenshuaining Capsules, Xueniao’an Capsules, Zhishe Tongluo Capsules, Yangyin Shengxue Mixture, Zaizao Shengxue Capsules, Antike Capsules and the Brucea Javanica Oil product series. As Leiyunshang’s flagship product, Liushen Pills was first documented in Houke Xinfa (Throat Medicine Essentials) in 1847, and its formula and production process have been designated as a national top secret. In recent years, the Group has actively conducted studies on drug repurposing of Liushen Pills and Liushen Capsules, using modern biomedical technologies to clarify the mechanisms by which Liushen Pills and Liushen Capsules act against respiratory viruses and to generate additional evidence for evidence-based clinical practice.

Quality determines survival and builds brand reputation. Leiyunshang Group exercises strict control over herbal material quality. By establishing herbal medicine cultivation bases in authentic producing regions, the Group strengthens quality management at the source and reinforces full-process safety control for pharmaceuticals. To date, it has set up 4 GAP-certified herbal medicine bases and partnered on the development of 49 bases, which guarantee the safety and efficacy of products. The system ensures that product origins are identifiable, distribution routes are traceable, quality records are verifiable, and responsibilities are accountable, effectively safeguarding quality and safety across all links of the industrial chain.

Leiyunshang Group deeply integrates the essence of traditional Chinese medicine with new-generation information technologies, building a modern intelligent manufacturing system featuring digitalized traditional craftsmanship, smart production processes, full-process quality control, and eco-friendly industrial development. Aligning with the strategies of “digital and intelligent empowerment, green manufacturing, and inheritance and innovation” set forth in the Implementation Plan for High-Quality Development of the Traditional Chinese Medicine Industry (2026–2030), the Group fully complies with the policy requirements of transforming and upgrading traditional industries via digital, intelligent and green technologies. It has emerged as a benchmark in the TCM industry driven by dual strengths of intelligent manufacturing as well as inheritance and innovation.